Rebiome A/S: Financial statements 2020
CVR: 41002212
Source: annual report 2020, Danish Business Authority
01/12/2019 – 30/09/2020
Rebiome A/S (CVR 41002212) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -515,211 and a net result of DKK -401,865. Equity in the 2020 report amounted to DKK 598,135. The solvency ratio was 57.3%.
- Gross Profit
- DKK -515,211
- Profit/Loss
- DKK -401,865
- Equity
- DKK 598,135
- Total Assets
- DKK 1,044,735
Official annual report
How creditworthy is Rebiome A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of September 24, 2020, Tine Pauline Sell Hellmann has joined the board of directors of Rebiome A/S.
As of September 24, 2020, Tine Pauline Sell Hellmann is registered as adm. dir. of Rebiome A/S.
As of September 24, 2020, Pernille Mette Ritlov has stepped down as director of Rebiome A/S.
As of September 23, 2020, Tine Pauline Sell Hellmann has left the board of directors of Rebiome A/S.
About Rebiome A/S
Rebiome A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2019. The company is registered under the industry Engroshandel med parfumerivarer og kosmetik. The management consists of Tine Pauline Sell Hellmann. The board consists of Sanne Wall-Gremstrup (chair), Amalie Victoria Hellmann Lykkesfeldt and Tine Pauline Sell Hellmann. The company is owned by PRO-MEDUC GROUP A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 65,437 and a net result of DKK 35,252 compared with DKK 387,741 the year before. Equity in the 2025 report amounted to DKK 1,039,305.